BICO Group AB (publ)
BICO Group AB (publ)
Your view on BCCOY
Overview
What the company does, where it operates, and who runs it.
About BICO Group AB (publ)
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Maria Forss
- Headquarters
- Arvid Wallgrens Backe 20, Gothenburg, SE
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Maria Forss
- Headquarters
- Arvid Wallgrens Backe 20, Gothenburg, SE
BICO Group AB (publ) operates as a bio convergence company in North America, Europe, Asia, and internationally. It operates through two segments, Laboratory Solutions and Bioautomation.
The Laboratory Solutions segment offers 3D bioprinters, hybrid microscopes, single-cell dispensing instruments, and liquid handling instruments, as well as services and related consumables, such as bioinks, reagents, microscope lenses, software, printheads, and 3D reconstructed human tissues for applications in regulatory testing.
This segment also offers services in 3D cell culture, 3D tissue imaging, multiplex imaging, and digital pathology to pharmaceutical and biotechnology companies.
The Bioautomation segment offers products in precision dispensing and biosensor technology to the industrial customer; and diagnostics automation and advanced robotics solutions for the medical and diagnostic industries.
In addition, it offers core industrial ecosystem, tissue engineering, multi-omics, cell line development, and diagnostics solutions. It primarily serves medical, pharmaceutical, and cosmetic industries. The company was formerly known as Cellink AB (publ) and changed its name to BICO Group AB (publ) in August 2021.
BICO Group AB (publ) was founded in 2016 and is based in Gothenburg, Sweden.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
Fair value for BICO Group AB (publ) from FRC's valuation model, read against the market price. BCCOY last traded at $0.38; the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for BICO Group AB (publ). Starting points for BICO Group AB (publ): EPS -$2.97, beta 2.78 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for BICO Group AB (publ). BICO Group AB (publ) does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for BICO Group AB (publ). Trailing twelve-month EPS for BICO Group AB (publ) stands at -$2.97. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Earnings Estimate
| EPS | Current QtrSep 2026 | Next QtrDec 2026 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | SEK 0.00 | SEK 0.00 | SEK 0.00 | SEK 0.00 |
| Low estimate | SEK 0.00 | SEK 0.00 | SEK 0.00 | SEK 0.00 |
| High estimate | SEK 0.00 | SEK 0.00 | SEK 0.00 | SEK 0.00 |
| No. of analysts | 0 | 0 | 0 | 0 |
| Year-ago EPS | -SEK 2.16 | -SEK 0.20 | -SEK 3.59 | — |
| Growth | +100.0% | +100.0% | +100.0% | — |
Revenue Estimate
| Revenue | Current QtrSep 2026 | Next QtrDec 2026 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | SEK 527.50M | SEK 468.00M | SEK 1.60B | SEK 1.60B |
| Low estimate | SEK 490.00M | SEK 468.00M | SEK 1.58B | SEK 1.56B |
| High estimate | SEK 565.00M | SEK 468.00M | SEK 1.62B | SEK 1.65B |
| No. of analysts | 2 | 2 | 1 | 2 |
| Year-ago revenue | SEK 381.23M | SEK 442.29M | SEK 1.41B | — |
| Growth | +38.4% | +5.8% | +13.6% | — |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep; as of Nov 12, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for BICO Group AB (publ). BICO Group AB (publ) has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
BICO Group AB (publ) valued side by side against its closest peers. BICO Group AB (publ) is measured against Medical - Devices peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
News
Latest headlines and market coverage.
Latest headlines and company announcements for BICO Group AB (publ). Coverage tracks BICO Group AB (publ) within Medical - Devices (Healthcare). Press releases and market coverage, newest first.
Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of BICO Group AB (publ).